Tessa Therapeutics

Tessa Therapeutics is a Singapore-based developer of T-cell immunotherapy for solid tumors, with its main product being the core virus-specific T-cell platform. This platform harnesses the antiviral immune response within patients to identify and eliminate cancer cells without harming healthy cells, thereby achieving safe and effective treatment outcomes.